The time of day a patient receives open-heart surgery could impact their postoperative outcomes, according to a new study in The Lancet.

Several of the late-breaking clinical trials presented at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Denver next week are sure to generate significant interest in the cardiology community. Some could even change practice, according to experts in the field.

Underweight women are at an increased risk for early menopause, which can lead to increased risk for heart disease, osteoporosis, dementia and death, a large-scale study published in Human Reproduction has found.

Five-minute interventions, “quit kits” and information delivered by peers all proved to be successful strategies for getting through to young smokers, research out of the University of California-Davis reports.

Patients with atrial fibrillation (AFib) who are treated with blood thinners are at a significantly reduced risk for developing dementia, according to research published Oct. 24 in the European Heart Journal. Individuals on oral anticoagulants (OACs) at baseline demonstrated a 29 percent lower risk of dementia compared to those not on blood thinners, while people treated with OACs throughout the study experienced a 48 percent risk reduction.

A new lab technique could cut testing time and improve the accuracy of coronary artery disease (CAD) diagnoses, new research published in Radiology states.

SAN CLEMENTE, Calif., Oct. 26, 2017 — ROX Medical Inc., a privately held medical device company pioneering an innovative interventional vascular therapy for uncontrolled hypertension, announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension.

New research published in PLOS One this October reports not only do more women statistically die of acute myocardial infarction (AMI) than men, but they see dramatically increased mortality in the first year after their heart attack.